News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 19, 2016, 18:00 ET Valeant Pharmaceuticals Receives Notice Of Default From Bondholders

Notice Does Not Accelerate Any of Valeant's Indebtedness Company Has Until July 18, 2016 to Cure Default By Filing Form 10-Q Company Continues to...


May 16, 2016, 19:00 ET Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters

Company Expects to File its 10-Q on or before June 10, 2016, as Previously Disclosed  Valeant Pharmaceuticals...


May 16, 2016, 08:00 ET Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that, pursuant to a...


May 09, 2016, 08:00 ET Valeant Pharmaceuticals Announces Expected Timing Of Form 10-Q Filing And Reiterates 2016 First Quarter Guidance

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it expects to file its...


May 05, 2016, 17:00 ET Valeant Pharmaceuticals Announces Patient Access And Pricing Committee To Oversee Pricing Of Drugs

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the formation of a new Patient...


May 05, 2016, 08:00 ET Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM

Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company,...


May 03, 2016, 07:00 ET Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Joseph C. Papa has assumed the role of Chairman and...


Apr 29, 2016, 09:31 ET Valeant Announces Nominees For Election To Board Of Directors

 Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX) (TSX: VRX) today announced the nominees for election to...


Apr 29, 2016, 07:28 ET Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015

 Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX) (TSX: VRX) today announced that it has filed with the...


Apr 25, 2016, 08:37 ET Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals

Brings More Than Three Decades of Leadership and Operations Experience in Healthcare Valeant Pharmaceuticals International,...


Apr 22, 2016, 17:30 ET Valeant Pharmaceuticals Receives Additional Notices Of Default Under Indentures Due To Delayed 10-K Filing

Notices Do Not Accelerate Any of the Company's Indebtedness The Company is on Schedule to File its 10-K on or before April 29, 2016, as Previously...


Apr 13, 2016, 18:00 ET Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters

Company is on Schedule to File its 10-K on or before April 29, 2016, as Previously Disclosed Valeant Pharmaceuticals International, Inc....


Apr 12, 2016, 17:00 ET Valeant Pharmaceuticals Receives Notice Of Default From Bondholders Due To Delayed 10-K Filing

Notice Does Not Accelerate Any of the Company's Indebtedness Company Has Until June 11, 2016 to Cure Default By Filing 10-K Company is on...


Apr 07, 2016, 07:30 ET Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment

Intends to File 10-K on or before April 29, 2016, as Previously Disclosed  Valeant Pharmaceuticals International, Inc. (NYSE: VRX and...


Apr 05, 2016, 08:48 ET Valeant Ad Hoc Committee Announces Completion Of Its Review Of Philidor And Related Accounting Matters

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the ad hoc committee of the board of directors (the "Ad...


Apr 04, 2016, 07:00 ET Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR

-Agency requests standard three-month extension to review additional solicited information- -New PDUFA date set for July 19, 2016- Valeant...


Mar 21, 2016, 08:58 ET Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update

Initiates Search for New CEO; J. Michael Pearson to Remain as CEO Until Successor is Named William A. Ackman Joins Board of Directors; Katharine...


Mar 15, 2016, 10:21 ET Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information

Company Provides New 2016 Guidance  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") today announced...


Mar 09, 2016, 17:30 ET Valeant And R&O Pharmacy End Litigation

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and R&O Pharmacy, LLC (R&O) today announced that they have jointly...


Mar 09, 2016, 08:00 ET Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Dr. Fred Eshelman, Mr. Stephen Fraidin and Mr. Thomas W....